Skip to content

Mindfulness-based Intervention for People With Parkinsonian Tremor

Pilot Study of the Ambulatory Monitoring Evaluation of a Mindfulness Meditation Programme in Parkinsonian Tremor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05168046
Acronym
MEDITAPARK
Enrollment
21
Registered
2021-12-23
Start date
2021-11-15
Completion date
2024-10-20
Last updated
2025-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease, Rest Tremor

Keywords

parkinson disease, rest tremor, mindfulness based intervention, sensors, embrassment

Brief summary

Mindfulness meditation is an approach that has shown interest in treatment of anxiety in Parkinson's disease. This pilot study aims to assess a more specific effect on tremor using Essential Tremor Embarrassment Assessment and inertial sensors allowing monitoring during sessions and in daily life. This study will focus on 20 patients (10 with and without Mindfulness based intervention and will aim to develop the interface and demonstrate proof of concept before setting up a controlled study

Detailed description

Methodology: Randomized, pilot study comparing 2 parallel arms (Mindfullness group versus group with routine care). Number of patients:20 Patient selection: patients with severe rest tremor Duration of project: 12 months Schedule visit: 4 visits in 6 months

Interventions

BEHAVIORALMindfulness based stress reduction

program of weekly mindfulness based stress reduction intervention during 2 months and practice during 3 months

Sponsors

Institut National de Recherche en Informatique et en Automatique
CollaboratorOTHER
Université Montpellier
CollaboratorOTHER
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Parkinson disease * Hoehn st and yahr stage \<or = 3 * Age between 35 and 85 years old * Treatment stabilized for at least 3 months * Disturbing parkinsonian tremor of the upper limb (item MDS -UPDRS 2.10\> 1) and lasting 2 to 6 hours per day * patients with internet access

Exclusion criteria

* Presence of disturbing dyskinetic movements (Item MDS-UPDRS4.2\> 1) * Patient who has already practiced meditation in the last 5 years * Untreated major depressive episode * Hallucinations (Item MDS-UPDRS1.2\> 1)) * Psychotic disorders - Confusional syndrome * presence of signs in favor of an atypical parkinsonian syndrome (oculomotor impairment, early falls, hallucinations, MoCA \<20, early dysautonomia) * adult protected by law (guardianship, curatorship or under legal protection) * deprivation of liberty by judicial or administrative decision * high probability of non-compliance with the protocol or abandonment during the study * refusal to sign informed consent * Pregnant or breastfeeding woman * Lack of social coverage.

Design outcomes

Primary

MeasureTime frameDescription
Essential Tremor Embarrassment Assessment scoreMonth 6 (M6)Essential Tremor Embarassment Assessment scale, ETEA : this scale is a self questionnaire made up of 14 items (0 to 5, 5 = worst embarrassment)

Secondary

MeasureTime frameDescription
duration of tremor assessed by agendaDay 0 (inclusion), Month 3 (M3)Weekly cumulative time differences of tremor periods on Hauser's modified auto-diary (2000)
duration of tremor assessed by sensors monitoringDay 0 (inclusion), Month 3 (M3)Weekly cumulative time differences of tremor periods recorded with the connected watch
feasability of the study : number of patients enrolledMonth 6 (M6)\- Proportion of patients included among screened patients
feasability of the study : number of patients ended the studyMonth 6 (M6)\- Proportion of patients who completed the meditation program
feasability of the study : hours of recording of the tremorMonth 6 (M6)\- Proportion of hours of recording of the tremor compared to the planned duration
feasability of the study : toleranceMonth 6 (M6)Tolerance to the meditation program assessed with a 10-point Likert scale
feasability of the study : COREQ 1Month 6 (M6)\- Focus Groups Consolidated Criteria for Reporting on Qualitative Studies (COREQ) 1
Severity tremor index assessed by sensors monitoringMonth 3 (M3)Differences in the Severity tremor index (mean amplitude of the tremor measured by the smartwatch)
Quality of life : Parkinson Disease Questionnaire 39 (PDQ39) scaleMonth 6 (M6)The PDQ39 scale is a self questionnaire made up of 39 items exploring 8 dimensions (mobility, daily activities, emotionnal well-being, psychological incomfort, social support, cogntive disorders, communication, physical incomfort). Description: Parkinson Disease Questionnaire 39 Quality of Life Score (PDQ39) (Auquier et al., 2002) - The PDQ-39 is a self-administered health-related Quality of Life (QOLL) instrument made up of 39 items exploring 8 dimensions (mobility , activity of daily living, emotional well-being, psychological discomfort, social support, cognitive disorders, communication, physical discomfort)
Quality of life : Hamilton anxiety and depression scale (HADS)Month 6 (M6)Depression score: Hamilton Anxiety and Depression Scale (Leentjeens, 2011) - This questionnaire assesses the presence and severity of anxiety and depressive symptoms. 14 questions, answers between 0 and 3, total score between 0 and 42, 42 is the worse outcome.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026